Akimitsu Yamada - Concepedia

Author

Akimitsu Yamada

Also Known As

A Yamada, A. YAMADA, A. Yamada, AKIMITSU YAMADA, Ai Yamada, Akimitsu YAMADA, Akimitsu Yamada, Ayano Yamada, Ayumi Yamada, Yamada, A.

330

Publications

Citations

H-Index

Concepts

All Affiliations

Yokohama City University Yokohama City University Medical Center Virginia Commonwealth University Tokyo Medical University Tohoku University

About

Akimitsu Yamada is an author at Yokohama City University specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.7K
2	Engineering	12	14	326
3	Natural Sciences	10	10	280
4	Health Sciences	2	2	52
5	Nursing	2	2	32

Akimitsu Yamada

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer Jie Liang, Masayuki Nagahashi, Eugene Y. Kim, Cancer Cell InflammationMucosal ImmunologyColitis-associated CancerMedicineImmunology	2012	550
Sphingosine-1-Phosphate Produced by Sphingosine Kinase 1 Promotes Breast Cancer Progression by Stimulating Angiogenesis and Lymphangiogenesis Masayuki Nagahashi, Subramaniam Ramachandran, Eugene Y. Kim, Cancer Research	2012	304
Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis Masayuki Nagahashi, Akimitsu Yamada, Eriko Katsuta, Cancer Research	2018	210
Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression Masayuki Nagahashi, Kazuaki Takabe, Runping Liu, Hepatology	2014	203
Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network Masayuki Nagahashi, Eugene Y. Kim, Akimitsu Yamada, The FASEB Journal	2012	157
Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden Omar M. Rashid, Masayuki Nagahashi, Subramaniam Ramachandran, Surgery Surgical OncologyMetastatic Breast CancerBreast OncologyMedicineCancer Management	2013	123
K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5 Kuzhuvelil B. Harikumar, Jessie Yester, Michael Surace, Nature Immunology InflammationCytokineK63-linked PolyubiquitinationSignal TransductionCell Regulation	2014	119
High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival Akimitsu Yamada, Takashi Ishikawa, Ikuko Ota, Breast Cancer Research and Treatment Tumor BiologyAggressive SubtypesBreast OncologyMedicineHigh Expression	2013	115
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer Nitai C. Hait, Dorit Avni, Akimitsu Yamada, Oncogenesis	2015	100
Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness Hidetaka Shima, Kumiko Kida, Shoko Adachi, Breast Cancer Research and Treatment Tumor BiologyBreast OncologyMedicineCancer GenomicsBreast Cancer	2018	95

Page 1